But what happens if business development begins to decrease while investors are waiting years for the share price to substantially increase?
Easily said from those that felt the evidence was clear and decisive about Sequest getting FDA approval in 2016. Investors sure got their payday.. from 39 cents to .035, a 91% COLLAPSE!!